In our study, we showed that monocytic S100A9+ MDSCs is well correlated to tumor infiltrating TAMs, and that NSCLC MDMs retained S100A9 and phenotypically had the M2 marker CD206. Here, S100A9 is linked to non-small cell lung carcinoma.